Equibles does not estimate personal net worth.
Get an email with a short summary when Praxis Precision Medicines, Inc. publishes a filing, an earnings call transcript or a press release.
Get PRAX alertsMegan Sniecinski is recorded as COO at Praxis Precision Medicines, Inc. (PRAX) since January 1, 2026. The newest filing on record that lists Megan Sniecinski as COO at Praxis Precision Medicines, Inc. (PRAX) is dated April 30, 2026. Praxis Precision Medicines, Inc. reported in an 8-K filed January 8, 2026 that Megan Sniecinski was appointed Chief Operating Officer, effective January 1, 2026. Megan Sniecinski has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Praxis Precision Medicines, Inc. on August 6, 2026. Praxis Precision Medicines, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Praxis Precision Medicines, Inc. includes Marcio Souza (CEO and Board Member), Timothy E. Kelly (CFO), Timothy Kelly (CFO) and 6 others.
“On January 8, 2026, Praxis Precision Medicines, Inc. (the "Company") announced the appointment of Megan Sniecinski as Chief Operating Officer of the Company, effective January 1, 2026 (the "Effective Date").”
“Not unexpectedly, these are hot launches upcoming. They each represent the first targeted therapies for indications with huge unmet needs. So it's allowed us, from a hiring perspective, to be very selective, and we're incredibly pleased with the caliber of the talent.”
“Building on a remarkable 2025, we've continued executing across our portfolio in our journey to become a commercial company and we're gaining momentum across all of our four late-stage assets.”
2026-01-01–present
Last confirmed April 30, 2026
Biotechnology · Healthcare
COO
2026-01-01–present
